Status:
COMPLETED
ESWT for Shoulder Pain in Patients With Brain Damage
Lead Sponsor:
Bundang CHA Hospital
Conditions:
Brain Damage, Hypoxic
Stroke
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
This study aimed to investigate the efficacy and safety of extracorporeal shockwave therapy (ESWT) for upper extremity pain related to spasticity in patients with spinal cord injury.
Detailed Description
6 times of ESWT (3,000 pulses per time, low energy under 0.3 mJ/mm\^2, tolerable range) on subscapularis and lesser and greater tuberlces of humerus to reduce pain in patients with brain damage
Eligibility Criteria
Inclusion
- Brain damaged patient confirmed in the brain image
- 1 month after brain damage
- Pain in hemiplegic shoulder areas more than 4 points on the numerical scale (NRS)
- Cognitive functions that can clearly point out NRS with more than 15 points in the mini mental state examination (MMSE)
- Age: 20 and older
- Person who has agreed in writing to decide his or her participation and comply with the precautions
Exclusion
- Pain due to trauma
- Injection treatments two weeks before participating in the study
- Severe coagulopathy (excluding antiplatelet use)
- Impaired cognition
Key Trial Info
Start Date :
May 29 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 11 2023
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT04320108
Start Date
May 29 2020
End Date
December 11 2023
Last Update
June 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Rehabilitation Medicine, CHA Bundang Medical Center
Seongnam, South Korea, South Korea, 13496